Cargando…
Higher baseline lipid levels amplify the benefit of secondary prevention therapy with statins in Chinese patients with acute coronary syndrome
OBJECTIVE: Statins are recommended as the first-line treatments for reducing the risk of major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS). The present study aimed to establish the baseline lipid levels associated with the greatest benefit from statin therapy...
Autores principales: | Zhu, Ling, Liu, Ying, Zhang, Wei, Zhang, Zhu, Zhou, Liqin, Zhang, Hong, Zhang, Yong, Liu, Fuqiang, Liu, Peng, Liu, Zhongwei, Wang, Junkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780582/ https://www.ncbi.nlm.nih.gov/pubmed/33138662 http://dx.doi.org/10.1177/0300060520965848 |
Ejemplares similares
-
Effects of a Secondary Prevention Combination Therapy with beta-Blocker and Statin on Major Adverse Cardiovascular Events in Acute Coronary Syndrome Patients
por: Zhu, Ling, et al.
Publicado: (2020) -
Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Im, Jihaeng, et al.
Publicado: (2021) -
Full-thickness myotomy is associated with higher rate of postoperative gastroesophageal reflux disease
por: Wang, Xue-Hong, et al.
Publicado: (2016) -
Statin escape phenomenon: Fact or fiction?
por: Barkas, Fotios, et al.
Publicado: (2017) -
Effect of calcium supplementation on severe hypocalcemia in patients with secondary hyperparathyroidism after total parathyroidectomy
por: Liu, Jun, et al.
Publicado: (2022)